Evidence map›Paper›PMID 34615581›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2021

Effectiveness of GenoType MTBDR

M Ejo, A Van Deun, A Nunn, S Meredith, S Ahmed, D Dalai, O Tumenbayar, B Tsogt, P T Dat, D T M Ha and 16 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

M EjoInstitute of Tropical Medicine, Antwerp, Belgium, University of Gondar, Gondar, Ethiopia, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
A Van DeunInstitute of Tropical Medicine, Antwerp, Belgium, Independent Consultant, Leuven, Belgium.
A NunnMedical Research Council Clinical Trials at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.
S MeredithMedical Research Council Clinical Trials at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.
S AhmedMedical Research Council Clinical Trials at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.
D DalaiNational Centre of Infectious Diseases, National Tuberculosis Reference Laboratory, Ulaanbaatar, Mongolia.
O TumenbayarNational Centre of Infectious Diseases, National Tuberculosis Reference Laboratory, Ulaanbaatar, Mongolia.
B TsogtMongolian TB Coalition, Ulaanbaatar, Mongolia.
P T DatPham Ngoc Thach Hospital, Ho Chi Minh, Vietnam.
D T M HaPham Ngoc Thach Hospital, Ho Chi Minh, Vietnam.
P T HangPham Ngoc Thach Hospital, Ho Chi Minh, Vietnam.
D KokebuSaint Peter´s TB Specialized Hospital, Addis Ababa, Ethiopia.
M TeferiArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
T MebrahtuArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
N NgubaneDoris Goodwin Hospital, Pietermaritzburg, South Africa.
R MoodliarKing Dinuzulu Hospital, Durban, South Africa.
L DuckworthKing Dinuzulu Hospital, Durban, South Africa.
F ConradieSizwe Tropical Disease, Johannesburg, South Africa.
E EnduwamahoroInstitute of Tropical Medicine, Antwerp, Belgium.
J KeysersInstitute of Tropical Medicine, Antwerp, Belgium.
P De RijkInstitute of Tropical Medicine, Antwerp, Belgium.
W MuldersInstitute of Tropical Medicine, Antwerp, Belgium.
E DiroUniversity of Gondar, Gondar, Ethiopia.
L RigoutsInstitute of Tropical Medicine, Antwerp, Belgium, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
B C de JongInstitute of Tropical Medicine, Antwerp, Belgium.
G TorreaInstitute of Tropical Medicine, Antwerp, Belgium.

Funding

Medical Research Council MC_EX_MR/J012513/1Medical Research Council MC_UU_00004/04Medical Research Council MC_UU_12023/26Medical Research Council MR/J012513/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mycobacterium tuberculosisTuberculosis, Multidrug-ResistantAntitubercular AgentsClinical Trials as TopicDrug ResistanceGenotypeHumansMicrobial Sensitivity TestsSensitivity and SpecificityAntitubercular Agents

Identifiers

PMID34615581
PMCPMC7614701

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.